期刊
NANOMEDICINE
卷 14, 期 11, 页码 1367-1370出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2019-0130
关键词
commercialization; cost taxonomy; cost-effectiveness analysis; nanotherapeutics; reimbursement